Medifast
MED
296 hedge funds and large institutions have $1.93B invested in Medifast in 2021 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 102 increasing their positions, 104 reducing their positions, and 41 closing their positions.
0.4% more ownership
Funds ownership: 84.84% → 85.24% (+0.4%)
2% less repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 104
5% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 41
2% less funds holding
Funds holding: 301 → 296 (-5)
28% less call options, than puts
Call options by funds: $13.4M | Put options by funds: $18.7M
32% less capital invested
Capital invested by funds: $2.82B → $1.93B (-$896M)
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Candlestick Capital Management
Greenwich,
Connecticut
|
+$26.8M |
| 2 |
NPIC
Neumeier Poma Investment Counsel
Carmel,
California
|
+$21.4M |
| 3 |
BlackRock
New York
|
+$19.1M |
| 4 |
CCPM
Cooper Creek Partners Management
New York
|
+$13.9M |
| 5 |
Millennium Management
New York
|
+$10.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
-$20.4M |
| 2 |
Morgan Stanley
New York
|
-$16.1M |
| 3 |
Renaissance Technologies
New York
|
-$13.3M |
| 4 |
Two Sigma Investments
New York
|
-$12M |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$11.4M |
MED Hedge Fund Activity: Q3 2021 in Review
296 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q3 2021, worth a combined $1.93B — down 32% from $2.82B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of MED and 39 opened new positions — a net loss of 2 holders — while 104 trimmed existing stakes and 102 added.
The largest buyer was Candlestick Capital Management, opening a new position worth an estimated $26.8M. The largest seller was Two Sigma Advisers, cutting an estimated $20.4M.
- 296 institutional investors held Medifast (MED) as of Q3 2021, down from 301 in Q2 2021.
- Funds reported $1.93B of Medifast stock for Q3 2021, down 32% quarter-over-quarter.
- 39 funds opened new Medifast positions in Q3 2021 and 41 closed out, a net change of -2 holders.
- The largest Medifast buyer in Q3 2021 was Candlestick Capital Management, an estimated $26.8M added.
- The largest Medifast seller in Q3 2021 was Two Sigma Advisers, an estimated $20.4M sold.
Based on aggregated 13F filings for Q3 2021.